[Sentinel lymph node biopsy in breast cancer treatment: efficacy and safety]
L'Institut national d'excellence en sante et en services sociaux (INESSS)
Record ID 32012000854
French
Authors' objectives:
In the context of breast cancer management in Québec, the Comité de l'évolution des pratiques en oncologie (CEPO) had questions regarding the efficacy, associated morbidity and safety of SLNB as part of breast cancer treatment. This committee asked the Unité d'évaluation en oncologie of the Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS), now the Institut national d'excellence en santé et en services sociaux (INESSS), to examine currently available evidence on these issues.
Authors' recommendations:
After analyzing the available literature, INESSS concludes that, in patients with early-stage breast cancer, without clinically detectable adenopathy, the use of axillary lymph node dissection following sentinel lymph node biopsy is not necessary when patients do not present with lymph node metastasis at the definitive anatomical pathology examination (pSLN-).
Details
Project Status:
Completed
Year Published:
2012
URL for published report:
http://www.inesss.qc.ca/fileadmin/doc/INESSS/Rapports/Oncologie/ETMIS2012_Vol8_No10.pdf
URL for additional information:
http://www.inesss.qc.ca/fileadmin/doc/INESSS/Rapports/Oncologie/INESSS_Summary_BGSIII_EN.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Breast Neoplasms
Contact
Organisation Name:
Institut national d'excellence en sante et en services sociaux
Contact Address:
L'Institut national d'excellence en sante et en services sociaux (INESSS) , 2021, avenue Union, bureau 10.083, Montreal, Quebec, Canada, H3A 2S9;Tel: 1+514-873-2563, Fax: 1+514-873-1369
Contact Name:
demande@inesss.qc.ca
Contact Email:
demande@inesss.qc.ca
Copyright:
L'Institut national d'excellence en sante et en services sociaux (INESSS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.